13.07.2015 Views

Official Proceedings - AIUM

Official Proceedings - AIUM

Official Proceedings - AIUM

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

American Institute of Ultrasound in Medicine <strong>Proceedings</strong> J Ultrasound Med 32(suppl):S1–S134, 20131522877 Many Faces of Uterine Adenomyosis: Ultrasound andMagnetic Resonance ImagingVijayanadh Ojili Radiology, University of Texas HealthScience Center, San Antonio, Texas USAObjectives—To describe the sonographic findings in differenttypes of uterine adenomyosis and correlate these with magnetic resonanceimaging (MRI) findings where available.Methods—A brief review of different types of uterine adenomyosis(diffuse adenomyosis, focal adenomyosis/adenomyoma, and cysticadenomyosis) will be presented. The sonographic findings will bedescribed and correlated with MRI findings. The potential role of newerultrasound techniques (3D sonography and elastosonography) and pertinentmanagement issues will be briefly discussed.Results—Not applicable as this is a pictorial review.Conclusions—Uterine adenomyosis is often misdiagnosed oris not easily recognized, although it is responsible for disabling symptomssuch as menorrhagia, dysmenorrhea, and infertility. Therefore, it is importantfor the radiologist to accurately diagnose this condition in a timelyfashion. Although MRI is the imaging modality of choice for comprehensiveevaluation, ultrasound is often the initial imaging test performedin the diagnostic workup of these patients and will provide a diagnosis inmost cases.1527190 Determining the Accuracy of Ultrasound in IdentifyingAxillary Lymph Node Metastasis in Breast Cancer PatientsMadelene Lewis,* Abid Irshad, Susan Ackerman Radiology,Medical University of South Carolina, Charleston, SouthCarolina USAObjectives—Axillary lymph node staging is the most importantprognostic indicator of outcome in breast cancer patients. A positivepercutaneous biopsy eliminates the need for sentinel lymph node (SLN)biopsy, saving patients discomfort, time, and money. The purpose of thisstudy was to evaluate our ability to predict axillary nodal involvementusing ultrasound (US) in patients with invasive breast cancer.Methods—After Institutional Review Board approval, a retrospectivereview was performed of 116 patients diagnosed with invasivebreast cancer between January 2010 and June 2011. Sonographic evaluationof the axilla was performed as part of our standard protocol for patientsundergoing biopsy of a breast mass at our institution. Lymph nodeswere considered positive by US if any of the following criteria were present:cortical thickness ≥3 mm, eccentric cortical thickening, cortical lobulation,loss of fatty hilum, or nonhilar blood flow. US findings werecorrelated with pathology results from fine-needle aspiration (FNA), coreneedle biopsy (CNB), SLN, and/or axillary lymph node dissection(ALND).Results—A total of 116 patients (all females) were diagnosedwith invasive breast cancer. Mean age was 58.6 ± 11.9 (SD) years (range,33–84 years) and included 69 white, 42 black, and 4 females from otherraces. Axillary US was performed in all 116 patients. Sonographically, 41patients had positive axillary lymph nodes, and 39 (95.1%) of these 41were sampled by FNA, CNB, SLN, or ALND. Metastatic disease waspositive in 28 (72%) of 39 patients. Of the 75 patients with negative axillaryUS, 68 patients had final pathology. Of these, 51 (75%) remainednegative on SLN or ALND, while 17 (25%) of 68 had metastatic nodes.The sensitivity, specificity, positive predictive value, and negative predictivevalue of US for predicting axillary metastasis were 72% (95% confidenceinterval [CI], 55%–84%), 75% (95% CI, 63%–84%), 62% (95%CI, 47%–76%), and 82% (95% CI, 70%–90%). The overall accuracy ofUS was 74%.Conclusions—Preoperative US evaluation of the axilla inbreast cancer patients is effective for determining metastatic nodes. However,an SLN biopsy is still required in patients with negative preoperativeUS.1527866 Equivalence of 2- and 3-Dimensional Ultrasound inthe Evaluation of First-Trimester Nuchal Translucency byMaternal-Fetal Medicine FellowsSteffen Brown,* Michael Wolfe, Lesley de la Torre, MatthewBrennan, Rebecca Hall Obstetrics and Gynecology, Universityof New Mexico, Albuquerque, New Mexico USAObjectives—Conflicting data exist that 3D ultrasound producesequivalent images to 2D for nuchal translucency (NT) assessment. Weaimed to prospectively evaluate the equivalence of 2D and 3D techniquesfor obtaining the NT measurement as performed by maternal-fetal medicinefellows.Methods—Prospectively enrolled subjects had first-trimesterscreening performed per protocol at our institution by a fellow in maternal-fetalmedicine under the supervision of an NT-certified sonologist.This included transabdominal imaging first, followed by endovaginal imagingif necessary to obtain the proper image. A 3D image using the sameapproach was then obtained and manipulated for measurement of the NT.The 2D and 3D measurements were then compared using a Fisher exacttest and Bland-Altman plot, including root mean squared (RMS) to quantifypaired differences.Results—A total of 43 women were enrolled in the study.Acceptable transabdominal NT measurements were obtained in 34 of the43 subjects (79%), and the remaining 9 (21%) required endovaginal assessmentto complete the exam. The differences in the NT measurementsusing 2D vs 3D nuchal translucency values were normally distributed bythe Shapiro-Wilk test (P = .97). The 2D and 3D values averaged 1.40 ±0.43 and 1.46 ± 0.49 mm, respectively. The 3D image did not significantlyovermeasure or undermeasure the NT (P = .69). 2D and 3D modalitiescorrelated within 3.7 mm (RMS) of one another. 3D imaging required anaverage of 105 seconds more than 2D to complete (P < .001), though totaltime for 3D averaged around 3 minutes (197 ± 179 seconds).Conclusions—2D and 3D NT measurements correlate closely.Performance and manipulation of a 3D volume sweep during NT assessmentmay provide an adjunct or confirmatory image.1528363 Comparative Effectiveness of Fetal Magnetic ResonanceImaging for Improvement of Diagnostic AccuracyChristina Herrera,* Amber Samuel, Sherelle Laifer-Narin,Lynn Simpson, Russell Miller Obstetrics and Gynecology,Columbia University Medical Center, New York, New York USAObjectives—Fetal magnetic resonance imaging (MRI) is performedas an adjunct to routine ultrasound with the intent of improving diagnosticaccuracy, yet data are limited to substantiate benefit to this costlyimaging modality. This study analyzed the billed cost of fetal MRI relativeto diagnostic information gained for patients with antenatal diagnosesof a fetal anomaly and known postnatal outcomes.Methods—This was a retrospective review of all fetal MRIsperformed between 2003 and 2011 at a tertiary care center. Potential caseswere identified if MRI was performed following sonographic concern fora fetal anomaly. Inclusion required documented neonatal outcomes orpostmortem assessments. Test performance characteristics were calculated,from which the number needed to secure an additional accurate diagnosisby MRI was determined. Applying the cost per MRI at the studycenter to this estimate, the cost per additional accurate diagnosis was calculated.Results—A total of 799 MRIs were performed, of which 406had documented neonatal or pathologic outcomes. One hundred thirtyonepostnatal diagnoses were secured, of which MRI identified 51 (12.6%)that ultrasound failed to correctly characterize. When the most common diagnosisgroups were considered, meningomyelocele had the lowest costper additional correct diagnosis by MRI and ventriculomegaly the highest(Table 1). The cost per additional accurate diagnosis for cases of congenitaldiaphragmatic hernia, omphalocele, vein of Galen malformation,S90

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!